SCHEMBL6600528

SCHEMBL6600528

Cc1c(-c2ccnc(Nc3ccc(N(C)C)cc3)n2)c(C)n(-n2c(C)c(-c3ccnc(Nc4ccc(F)cc4)n3)c(C)c2C(N)=O)c1C#N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 14/20 0.50
CDK4 P11802 10/20 0.50
CCNE1 P24864 2/20 0.41
AURKA O14965 1/20 0.40
CDK1 P06493 1/20 0.40
CDK7 P50613 1/20 0.40
CDK9 P50750 1/20 0.40
AURKB Q96GD4 1/20 0.40
PARP1 P09874 1/20 0.39
EIF2AK2 P19525 1/20 0.38
IKBKB O14920 1/20 0.38
ABL1 P00519 1/20 0.36
BCR P11274 1/20 0.36
KCNH2 Q12809 1/20 0.36
MAPK8 P45983 1/20 0.36
MAPK10 P53779 1/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6599785 0.88 CDK2 (0.52) CDK2CDK4CDK9EIF2AK2KCNH2
SCHEMBL6597472 0.81 CDK2 (0.49) CDK2CDK4CCNE1AURKACDK1
SCHEMBL4613643 0.78 CDK2 (0.50) CDK2CDK4CCNE1AURKACDK1
SCHEMBL6600525 0.76 CDK2 (0.74) CDK2CDK4CCNE1AURKACDK1
SCHEMBL6600211 0.70 CDK4 (0.58) CDK2CDK4AURKBEIF2AK2KCNH2
SCHEMBL6601086 0.69 CDK2 (0.58) CDK2CDK4CDK1CDK7CDK9
SCHEMBL4616002 0.67 CDK2 (1.00) CDK2CDK4EIF2AK2MAPK8MAPK10
SCHEMBL4615032 0.67 CDK2 (0.77) CDK2CDK4CCNE1AURKACDK1
SCHEMBL6277074 0.67 CDK2 (0.53) CDK2CDK4CCNE1CDK1CDK7
SCHEMBL6600190 0.67 CDK4 (0.58) CDK2CDK4AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373253-A1 INHIBITORS OF CYCLIN DEPENDENT KINASES AS ANTI-CANCER AGENT Cyclacel Limited (GB) 2004-01-02 EP claimed
WO-2002079193-A1 INHIBITORS OF CYCLIN DEPENDENT KINASES AS ANTI-CANCER AGENT CYCLACEL LIMITED (GB) 2002-10-10 WO claimed